University of Patras
Αλληλεπιδράσεις των συστημάτων νευροδιαβίβασης ντοπαμίνης/αδενοσίνης στον εγκέφαλο των "weaver" μυών, γενετικού μοντέλου ντοπαμινεργικής απονεύρωσης
Abstract
dc:descriptionThe present work studied the antagonistic interaction of A1/D1 receptors at the level of mRNA expression of the immediate early gene zif/268 (used as a marker of neuronal function). In parallel we studied the in vivo signal transduction of A1 and A2A adenosine receptors under dopamine deficiency in weaver mutant. The weaver mutant represents the only genetic animal model of gradual nigrostriatal neuron degeneration which can be characterized as a pathophysiological phenocopy of Parkinson s disease. In the first part of the study the co-activation of A1 and D1 receptors revealed the well-known antagonistic interaction of these receptors (possibly through the formation of A1/D1 heterodimer) in weaver mutant. An interesting result was that the activation of A1 receptors alone did induce zif/268 mRNA expression in striatal and specific cortical neurons in weaver mutant. This induction was not expected since A1 receptors are Gi coupled and suppress the signal transduction pathway that leads to zif/268 induction through AC/PKA/p DARPP 32/pCREB cascade. Further study revealed that the A1 receptor induced zif/268 mRNA expression iscounteracted by the A2A receptor selective antagonist ZM241385 and by the D2 receptor selective agonist Quinpirole suggesting the activation of A2A receptors and thus the activation of the indirect pathway. Moreover A1 receptors activation induced the expression of enkephalin mRNA but not of dynorphin which are considered as marker of neuronal activation of the indirect and the direct pathway respectively. The fact that the A1 receptor agonist did not induced zif/268 mRNA expression in +/+ animals indicates that under dopamine deficiency the A2A receptors react with a supersensitive response. This response was analyzed in weaver mouse after in vivo A2A receptor activation a) by examining the classical signal transduction pathway of A2A receptors/AC/PKA/p DARPP 32/pCREB which leads to zif/268 expression and b) by studying the MAPK cascade. Results showed increased basal phosphorylation levels of DARPP 32 (dopamine and cAMP regulated phosphoprotein MW 32kDa) of Thr 34 in weaver compared to control mice. Increased phosphoThr34 DARPP 32 would amplify the effects of the PKA and thus facilitating the signal transduction through A2A receptors/AC/PKA/p DARPP 32/pCREB. Therefore the A2A receptors supersensitive response under dopamine deficiency in weaver mutant seems to be due to elevated endogenous phosphorylation levels of DARPP 32. Interestingly while the basal phosphorylation levels of ERK1/2 (MAPK44/42) are elevated in weaver mutant they are significantly reduced after A2A receptor activation. Although we do not know the mechanism through which the endogenous ERK1/2 levels are elevated the conclusion is that under dopamine deficiency A2A receptors do not activate MAPK cascade. The present in vivo study demonstrates the role of A1 and A2A adenosine receptors in the function of basal ganglia under dopamine deficiency. Our results are significant since the experiments were performed in a genetic parkinsonian model in which the dopaminergic neurons are gradually degenerated and thus simulate the human PD and not in an acute toxic model. Moreover these results could be of possible clinical relevance since the activation of A1 receptors by endogenous adenosine would exaggerate the motor dysfunctions of PD. Furthermore the enhanced signal transduction pathway through A2A receptors supports the suggestion that the A2A receptor antagonists as antiparkinsonian agents. Given the well-known A2A/D2 antagonistic interaction new therapeutical prospectives would involve the development of pharmacological bivalent ligands which can interact with the A2A/D2 receptors and act simultaneously as A2A receptor antagonists and as D2 receptor agonists.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Poulou, Paraskevi
- Πούλου, Παρασκευή
Subjects
dc:subject × 24- Υποδοχείς ντοπαμίνης
- Υποδοχείς αδενοσίνης
- Έκφραση πρώιμων γονιδίων (zif/268)
- Μεταβίβαση σήματος (DARPP-32)
- Βασικά γάγγλια
- Ασθένεια Πάρκινσον
- Νευροπεπτίδια
- Εγκεφαλίνη
- Δυνορφίνη
- Γενετικό μοντέλο weaver
- Dopamine receptors
- Adenosine receptors
- Immediate early gene expression (zif/268)
- Signal transduction (DARPP-32)
- Basal ganglia
- Parkinson's disease
- Neuropeptides
- Enkephalin
- Dynorphin
- Genetic model weaver
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25754